MyAverix Finance
SHE · Healthcare
Shanghai Universal Biotech Co.Ltd. (301166)
Biotechnology
Shanghai Universal Biotech Co.Ltd. (301166) is listed on SHE in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $2.63B, P/E ratio is 18.00, net margin is -1.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 301166
Shanghai Universal Biotech Co.Ltd. (301166) — FAQ
What is Shanghai Universal Biotech Co.Ltd.'s market cap?
Shanghai Universal Biotech Co.Ltd. (301166) has a reported market cap of $2.63B (data as of 2026-03-29).
What is 301166's P/E ratio?
The price-to-earnings (P/E) ratio for Shanghai Universal Biotech Co.Ltd. (301166) is 18.00 (data as of 2026-03-29).
Does Shanghai Universal Biotech Co.Ltd. pay a dividend?
Dividend yield is not available in the current snapshot for Shanghai Universal Biotech Co.Ltd. (301166). Check the MyAverix Finance app for the latest dividend data.
What sector is Shanghai Universal Biotech Co.Ltd. in?
Shanghai Universal Biotech Co.Ltd. (301166) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 301166 listed on?
301166 is listed on SHE.
What is Shanghai Universal Biotech Co.Ltd.'s net margin?
Shanghai Universal Biotech Co.Ltd. (301166) reports a net margin of -1.8% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.